IDOGEN — Idogen AB Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- SEK12.58m
- SEK9.60m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 27.9 | 32.8 | 26.2 | 39 | 48 |
Operating Profit | -27.9 | -32.8 | -26.2 | -39 | -48 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -27.6 | -32.7 | -26.8 | -38.9 | -47.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -27.6 | -32.7 | -26.8 | -38.9 | -47.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -27.6 | -32.7 | -26.8 | -38.9 | -47.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -27.6 | -32.7 | -26.8 | -38.9 | -47.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4.28 | -4.36 | -2.8 | -1.7 | -0.761 |
Dividends per Share |